ESPE Abstracts

GH Dosing Patterns in Short Children Born Small for Gestational Age | ESPE2014
Isabelle Oliver Petit; Oliver Blankenstein; Dragan Zdravkovic; Pedersen Birgitte Tonnes; Effie Pournara
http://abstracts.eurospe.org/hrp/0082/hrp0082p2-d3-439.htm
Published: 2014-08-28

Final Results of NordiNet® International Outcome Study: Key Outcomes in Paediatric Patients | ESPE2018
Michel Polak; Jo Blair; Tilman R. Rohrer; Alberto Pietropoli; Pedersen Birgitte Tonnes; Lars Savendahl
http://abstracts.eurospe.org/hrp/0089/hrp0089p2-p252.htm
Published: 2018-08-28

The Association between Growth Hormone Dose and Short-Term Height Outcomes in a Large Cohort of Paediatric Patients with Turner Syndrome: Real-World Data from the NordiNet® International Outcome Study (IOS) and ANSWER Program | ESPE2018
Jo Blair; Tilman R. Rohrer; Pedersen Birgitte Tonnes; Sebastian Roehrich; Philippe Backeljauw
http://abstracts.eurospe.org/hrp/0089/hrp0089p1-p163.htm
Published: 2018-08-28

Real-World Safety Data in a Cohort of Children with Noonan Syndrome Treated with GH: Final Results from NordiNet International Outcome Study (IOS) and ANSWER Program | ESPE2018
Petur Benedikt Juliusson; Jovanna Dahlgren; M Jennifer Abuzzahab; Birgitte Tonnes Pedersen; Sebastian Roehrich; Alicia Romano
http://abstracts.eurospe.org/hrp/0089/hrp0089p1-p212.htm
Published: 2018-08-28

An Analysis of the Safety of Childhood Growth Hormone (GH) Therapy: Data from the NordiNet® International Outcome Study (IOS) | ESPE2016
Lars Savendahl; Tilman R Rohrer; Effie Pournara; Birgitte Tonnes Pedersen; Oliver Blankenstein
http://abstracts.eurospe.org/hrp/0086/hrp0086p2-p643.htm
Published: 2016-08-19

Glucose Dysregulation in Children with Growth Hormone Deficiency (GHD), Turner Syndrome (TS) or Born Small for Gestational Age (SGA) Treated with GH: A Report from the NordiNet International Outcome Study (IOS) | ESPE2016
Primoz Kotnik; Tilman Rohrer; Birgitte Tonnes Pedersen; Effie Pournara; Henrik Christesen
http://abstracts.eurospe.org/hrp/0086/hrp0086p1-p613.htm
Published: 2016-08-19

Time Trends in Baseline Characteristics (2006-2014) in Short Children with Growth Hormone Deficiency (GHD), Born Small for Gestational Age (SGA) and with Ullrich-Turner Syndrome (TS) Enrolled in Nordinet[reg] International Outcomes Study (IOS) in Germany and Czech Republic | ESPE2015
Helmuth Gunther Dorr; Jurgen Bramswig; Stefanie Meckes-Ferber; Effie Pournara; Birgitte Tonnes Pedersen; Marta Snajderova
http://abstracts.eurospe.org/hrp/0084/hrp0084p3-972.htm
Published: 2015-08-26

GH Dosing Patterns in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency Enrolled in the NordiNet[reg] International Outcome Study | ESPE2015
Marta Snajderova; Effie Pournara; Birgitte Tonnes Pedersen; Oliver Blankenstein
http://abstracts.eurospe.org/hrp/0084/hrp0084p3-940.htm
Published: 2015-08-26

Safety Evaluation of Long-Term Recombinant GH Treatment in Childhood: Interim Analysis of the NordiNet[reg] International Outcome Study (IOS) | ESPE2015
Lars Savendahl; Effie Pournara; Tilman R Rohrer; Birgitte Tonnes Pedersen; Marja-Terttu Saha; Oliver Blankenstein
http://abstracts.eurospe.org/hrp/0084/hrp0084p2-419.htm
Published: 2015-08-26

Normal Onset of Clinical Puberty for Age in GH-Treated Children with Noonan Syndrome or Turner Syndrome: Data from the NordiNet<SUP>&#174;</SUP> IOS and ANSWER<SUP>&#174;</SUP> Program | ESPE2014
Judith Ross; Henrik Christesen; Peter Lee; John Germak; Birgitte Tonnes Pedersen; Primoz Kotnik
http://abstracts.eurospe.org/hrp/0082/hrp0082p2-d2-423.htm
Published: 2014-08-28